Home›Search›Farmakoekonomika

Farmakoekonomika

IRBIS LLC · Russian Federation · Est. 2015

ISSN2070-4933

SJR Q4✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Risk

Score Breakdown

✓ Scopus Q4+5

✓ DOAJ Verified+15

Total20

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

0.143

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.246

Total Works

470

Total Citations

1,189

2yr Mean Citedness

0.87

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on pharmacoeconomic evaluations, including cost-effectiveness analyses, budget impact assessments, and analyses of drug availability and pricing. It examines pharmaceutical markets, the economic efficiency of diagnostic and treatment strategies, and the impact of various therapies on healthcare systems and patients. The scope also includes pharmacovigilance and the analysis of adverse drug reactions, as well as the systematization of pharmacological data for specific drugs.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Fast · median is 15 wks

SJR Rank

Bottom 25%

General Information

Country / RegionRussian Federation

Primary LanguageRussian

1st Year Published2015

Annual Volume~ 53 articles / year

StatusActive (last: 2026)

Total Publications470

OA Since2014

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

Review Time~8 weeks

Acceptance Rate—

OA LicenseCC BY-NC-SA

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

Russian State Library

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

IRBIS LLC

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2070-4933

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Russian State Library

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

Russian

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Health PolicyQ4

PharmacologyQ4

Public Health, Environmental and Occupational HealthQ4

Subject Classification

Scopus Categories

PharmacologyPublic Health, Environmental and Occupational HealthHealth Policy

Research Topics (OpenAlex)

Healthcare Systems and Public HealthHealth Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyEconomic, Social, and Public Health Issues in Russia and GloballyEconomic and Financial Impacts of CancerHuman Health and DiseaseRespiratory and Cough-Related ResearchComputational Drug Discovery MethodsAsthma and respiratory diseasesPharmaceutical studies and practices